Compare Diageo plc (DEO) vs Iovance Biotherapeutics Inc. Common Stock (IOVA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Diageo plc vs Iovance Biotherapeutics Inc. Common Stock — how do they compare? Diageo plc trades at $87.35 (market cap $47.54B), while Iovance Biotherapeutics Inc. Common Stock trades at $13.36 (market cap $5.85B). The key difference: Diageo plc is far larger — about 8.1× Iovance Biotherapeutics Inc. Common Stock's market cap, and Diageo plc pays a 2.36% dividend while Iovance Biotherapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Diageo plc for 66 Days and Iovance Biotherapeutics Inc. Common Stock for 0 Days on average.
| DEO | IOVA | |
|---|---|---|
Market Cap | $47.54B | $5.85B |
Volume | 1,824,704 | 14,517,176 |
Sector | Consumer Staples | Health |
52-Week High | $102.14 | $14.82 |
52-Week Low | $72.47 | $1.81 |
Typical Hold Time | 66 Days | 0 Days |
Enterprise Value | $67.96B | $5.78B |
Dividend Yield | 2.36% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Diageo (DEO) trades at $84.73, down slightly by 0.06% on the day, with a bearish technical signal from moving averages. The company shows solid profitability with a 59.47% gross margin and has beaten EPS estimates in the last three quarters. Recent news highlights marketing initiatives and a CFO transition planned for 2027, while analyst consensus leans positive with 49% buy ratings.
The outlook is mixed: cost-cutting and brand investments support a turnaround, but declining 2026 revenue and net income projections pose risks. Valuation ratios like P/E of 27.19 suggest premium pricing, requiring execution success to justify. Key risks include U.S. market challenges and regulatory scrutiny in regions like India.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Diageo plc
Diageo is a global leader in beverage alcohol with an outstanding collection of brands including Johnnie Walker, Smirnoff, and Guinness. It operates a vast portfolio of spirits and beers across more than 180 countries.
Read more on DEO →About Iovance Biotherapeutics Inc. Common Stock
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →
